Abstract
Tumor suppressor protein p53 plays a central role in maintaining genomic integrity. p53 induces cell cycle arrest and apoptosis by transactivating the expression of downstream target genes in response to genotoxic stress. Tetramer formation of p53 is essential for its activity. The aims of this study were to reveal the dysfunction threshold of p53 caused by destabilization of its tetrameric structure. In Chap. 2, we demonstrated that a relatively small destabilization of the tetrameric structure by the missense mutation could induce significantly decreased amounts of the tetramer in the nucleus. In Chaps. 3 and 4, functional control of p53 via tetramer formation was performed; in Chap. 3, tumor-associated mutants were rescued by stabilization of the tetrameric structure using calixarene derivatives and in Chap. 4, transcriptional activity of p53 was inhibited by hetero-oligomerization.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meek DW (2009) Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 9:714–723
Meek DW, Anderson CW (2009) Posttranslational modification of p53: cooperative integrators of function. Cold Spring Harb Perspect Biol 1:a000950
Rodier F, Campisi J, Bhaumik D (2007) Two faces of p53: aging and tumor suppression. Nucleic Acids Res 35:7475–7484
Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387:296–299
Picksley SM, Lane DP (1993) The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53? BioEssays 15:689–690
Speidel D (2010) Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20:14–24
Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K (2009) Modulation of microRNA processing by p53. Nature 460:529–533
Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444–448
Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285:1733–1737
Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460:1132–1135
Zhang Y, Xiong Y (2001) A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292:1910–1915
Anderson ME, Woelker B, Reed M, Wang P, Tegtmeyer P (1997) Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation. Mol Cell Biol 17:6255–6264
Mazur SJ, Sakaguchi K, Appella E, Wang XW, Harris CC, Bohr VA (1999) Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain. J Mol Biol 292:241–249
Hupp TR, Meek DW, Midgley CA, Lane DP (1992) Regulation of the specific DNA binding function of p53. Cell 71:875–886
Balagurumoorthy P, Sakamoto H, Lewis MS, Zambrano N, Clore GM, Gronenborn AM, Appella E, Harrington RE (1995) Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. Proc Natl Acad Sci U S A 92:8591–8595
Halazonetis TD, Kandil AN (1993) Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J 12:5057–5064
Nagaich AK, Zhurkin VB, Durell SR, Jernigan RL, Appella E, Harrington RE (1999) p53-induced DNA bending and twisting: p53 tetramer binds on the outer side of a DNA loop and increases DNA twisting. Proc Natl Acad Sci U S A 96:1875–1880
Anderson CW, Appella E, Sakaguchi K (1998) Posttranslational modifications involved in the DNA damage response. J Protein Chem 17:527
Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E, Fornace AJJ (1999) Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18:6845–6854
Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677–1679
Higashimoto Y, Saito S, Tong XH, Hong A, Sakaguchi K, Appella E, Anderson CW (2000) Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J Biol Chem 275:23199–23203
Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E, Anderson CW (1992) Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 12:5041–5049
Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11:3471–3481
Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E (2000) Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 275:9278–9283
Kar S, Sakaguchi K, Shimohigashi Y, Samaddar S, Banerjee R, Basu G, Swaminathan V, Kundu TK, Roy S (2002) Effect of phosphorylation on the structure and fold of transactivation domain of p53. J Biol Chem 277:15579–15585
Polley S, Guha S, Roy NS, Kar S, Sakaguchi K, Chuman Y, Swaminathan V, Kundu T, Roy S (2008) Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains. J Mol Biol 376:8–12
Pise-Masison CA, Radonovich M, Sakaguchi K, Appella E, Brady JN (1998) Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol 72:6348–6355
Anderson CW, Appella E (2011) Signaling to the p53 tumor suppressor through pathways activated by genotoxic and nongenotoxic stress. In: Bradshaw RA, Dennis EA (eds) Regulation in Organella and Cell Compartment Signaling, Chap 264, Elsevier BV, CA, pp 235–254
Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12:2831–2841
Sakaguchi K, Sakamoto H, Lewis MS, Anderson CW, Erickson JW, Appella E, Xie D (1997) Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36:10117–10124
Li AG, Piluso LG, Cai X, Wei G, Sellers WR, Liu X (2006) Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 23:575–587
Pavithra L, Mukherjee S, Sreenath K, Kar S, Sakaguchi K, Roy S, Chattopadhyay S (2009) SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription. J Mol Biol 388:691–702
Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP (1996) Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274:948–953
Di Lello P, Jenkins LM, Jones TN, Nguyen BD, Hara T, Yamaguchi H, Dikeakos JD, Appella E, Legault P, Omichinski JG (2006) Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol Cell 22:731–740
Rustandi RR, Baldisseri DM, Weber DJ (2000) Structure of the negative regulatory domain of p53 bound to S100B(betabeta). Nat Struct Biol 7:570–574
Joerger AC, Fersht AR (2008) Structural biology of the tumor suppressor p53. Annu Rev Biochem 77:557–582
Sakamoto H, Lewis MS, Kodama H, Appella E, Sakaguchi K (1994) Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution. Proc Natl Acad Sci U S A 91:8974–8978
Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E, Gronenborn AM (1994) High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science 265:386–391
Clubb RT, Omichinski JG, Sakaguchi K, Appella E, Gronenborn AM, Clore GM (1995) Backbone dynamics of the oligomerization domain of p53 determined from 15 N NMR relaxation measurements. Protein Sci 4:855–862
Miller M, Lubkowski J, Rao JKM, Danishefsky AT, Omichinski JG, Sakaguchi K, Sakamoto H, Appella E, Gronenborn AM, Clore GM (1996) The oligomerization domain of p53: crystal structure of the trigonal form. FEBS Lett 399:166–170
Clore GM, Ernst J, Clubb R, Omichinski JG, Kennedy WMP, Sakaguchi K, Appella E, Gronenborn AM (1995) Refined solution structure of the oligomerization domain of the tumour suppressor p53. Nat Struct Biol 2:321–333
Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E, Gronenborn AM (1995) Interhelical angles in the solution structure of the oligomerization domain of p53: correction. Science 267:1515–1516
Jeffrey PD, Gorina S, Pavletich NP (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267:1498–1502
Johnson CR, Morin PE, Arrowsmith CH, Freire E (1995) Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor. Biochemistry 34:5309–5316
Tidow H, Melero R, Mylonas E, Freund S, Grossmann JG, Carazo JM, Svergun DI, Valle M, Fersht AR (2007) Quaternary structures of tumor suppressor p53 and a specific p53–DNA complex. Proc Natl Acad Sci U S A 104:12324–12329
Malecka KA, Ho WC, Marmorstein R (2009) Crystal structure of a p53 core tetramer bound to DNA. Oncogene 28:325–333
McLure KG, Lee PW (1998) How p53 binds DNA as a tetramer. EMBO J 17:3342–3350
Chene P (2001) The role of tetramerization in p53 function. Oncogene 20:2611–2617
Ullrich SJ, Sakaguchi K, Lees-Miller SP, Fiscella M, Mercer WE, Anderson CW, Appella E (1993) Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc Natl Acad Sci U S A 90:5954–5958
van Dieck J, Fernandez–Fernandez MR, Veprintsev DB, Fersht AR (2009) Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J Biol Chem 284:13804–13811
Delphin C, Ronjat M, Deloulme JC, Garin G, Debussche L, Higashimoto Y, Sakaguchi K, Baudier J (1999) Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53. J Biol Chem 274:10539–10544
Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, Wahl GM (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18:1660–1672
Sakaguchi K, Sakamoto H, Xie D, Erickson JW, Lewis MS, Anderson CW, Appella E (1997) Effect of phosphorylation on tetramerization of the tumor suppressor protein p53. J Protein Chem 16:553–556
Sakamoto H, Kodama H, Higashimoto Y, Kondo M, Lewis MS, Anderson CW, Appella E, Sakaguchi K (1996) Chemical synthesis of phosphorylated peptides of the carboxy-terminal domain of human p53 by a segment condensation method. Int J Pept Protein Res 48:429–442
Mateu MG, Fersht AR (1998) Nine hydrophobic side chains are key determinants of the thermodynamic stability and oligomerization status of tumour suppressor p53 tetramerization domain. EMBO J 17:2748–2758
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2012 Springer Japan
About this chapter
Cite this chapter
Kamada, R. (2012). General Introduction. In: Tetramer Stability and Functional Regulation of Tumor Suppressor Protein p53. Springer Theses. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54135-6_1
Download citation
DOI: https://doi.org/10.1007/978-4-431-54135-6_1
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54134-9
Online ISBN: 978-4-431-54135-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)